cytochrome-c-t and salsolinol

cytochrome-c-t has been researched along with salsolinol* in 2 studies

Other Studies

2 other study(ies) available for cytochrome-c-t and salsolinol

ArticleYear
Salsolinol, a catechol neurotoxin, induces oxidative modification of cytochrome c.
    BMB reports, 2013, Volume: 46, Issue:2

    Methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (salsolinol), an endogenous neurotoxin, is known to perform a role in the pathogenesis of Parkinson's disease (PD). In this study, we evaluated oxidative modification of cytochrome c occurring after incubation with salsolinol. When cytochrome c was incubated with salsolinol, protein aggregation increased in a dosedependent manner. The formation of carbonyl compounds and the release of iron were obtained in salsolinol- treated cytochrome c. Salsolinol also led to the release of iron from cytochrome c. Reactive oxygen species (ROS) scavengers and iron specific chelator inhibited the salsolinol-mediated cytochrome c modification and carbonyl compound formation. It is suggested that oxidative damage of cytochrome c by salsolinol might induce the increase of iron content in cells, subsequently leading to the deleterious condition which was observed. This mechanism may, in part, provide an explanation for the deterioration of organs under neurodegenerative disorders such as PD.

    Topics: Animals; Cell Line, Tumor; Copper; Cytochromes c; DNA Damage; Iron; Isoquinolines; Neurotoxins; Oxidative Stress; Protein Carbonylation; Rats; Reactive Oxygen Species

2013
Salsolinol, an endogenous neurotoxin, activates JNK and NF-kappaB signaling pathways in human neuroblastoma cells.
    Neurochemical research, 2007, Volume: 32, Issue:3

    Salsolinol, an endogenous neurotoxin, is known to be involved in the pathogenesis of Parkinson's disease (PD). In the present study, we have investigated the effects of salsolinol on the activation of two different signaling pathways that involve c-Jun N-terminal kinase (JNK), and nuclear factor-kappaB, (NF-kappaB) in human dopaminergic neuroblastoma SH-SY5Y cells. Salsolinol treatment caused upregulation in the levels of c-Jun and phosphorylated c-Jun. It also caused degradation of IkappaBalpha and translocated the active NF-kappaB into the nucleus. The binding activity of NF-kappaB to DNA was enhanced by salsolinol in a concentration dependent manner. Furthermore, salsolinol decreased the levels of the anti-apoptotic protein Bcl-2, and increased pro-apoptotic protein Bax, while enhancing the release of cytochrome-c from mitochondria. Mitochondrial complex-I activity was significantly decreased and reactive oxygen species (ROS) were increased in salsolinol treated cells. These results partly suggest that salsolinol-induced JNK and NF-kappaB signaling pathways may be involved in induction of apoptosis in human dopaminergic neurons, as seen in Parkinson's disease.

    Topics: Cell Line, Tumor; Cytochromes c; Electron Transport Complex I; Humans; Isoquinolines; JNK Mitogen-Activated Protein Kinases; Mitochondria; Neuroblastoma; NF-kappa B; Phosphorylation; Reactive Oxygen Species; Signal Transduction

2007